CNPFX
Price
$71.79
Change
-$0.20 (-0.28%)
Updated
Sep 17 closing price
Net Assets
162.63B
LSAGX
Price
$25.25
Change
+$0.09 (+0.36%)
Updated
Sep 17 closing price
Net Assets
141.03M
Interact to see
Advertisement

CNPFX vs LSAGX

Header iconCNPFX vs LSAGX Comparison
Open Charts CNPFX vs LSAGXBanner chart's image
American Funds New Perspective 529F
Price$71.79
Change-$0.20 (-0.28%)
VolumeN/A
Net Assets162.63B
Loomis Sayles Global Growth A
Price$25.25
Change+$0.09 (+0.36%)
VolumeN/A
Net Assets141.03M
CNPFX vs LSAGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNPFX vs. LSAGX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Buy and LSAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 163B vs. LSAGX (141M). CNPFX pays higher dividends than LSAGX: CNPFX (0.64) vs LSAGX (0.00). CNPFX was incepted earlier than LSAGX: CNPFX (23 years) vs LSAGX (9 years). LSAGX (1.38) is less costly to investors than CNPFX (0.84). CNPFX is a more actively managed with annual turnover of: 24.00 vs. LSAGX (6.00). CNPFX has a lower initial minimum investment than LSAGX: CNPFX (250) vs LSAGX (2500). LSAGX annual gain was more profitable for investors over the last year : 30.69 vs. CNPFX (14.87). LSAGX return over 5 years is better than : 48.53 vs. CNPFX (41.03).
CNPFXLSAGXCNPFX / LSAGX
Total Expense Ratio0.841.2070%
Annual Report Gross Expense Ratio0.841.3861%
Fund Existence23 years9 years-
Gain YTD18.27022.81180%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets163B141M115,603%
Annual Yield % from dividends0.640.00-
Returns for 1 year14.8730.6948%
Returns for 3 years53.1988.4360%
Returns for 5 years41.0348.5385%
Returns for 10 years114.59N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS5.790.05
+0.87%
Corvus Pharmaceuticals
CR180.66-2.13
-1.17%
Crane Company
OI12.60-0.19
-1.49%
O-I Glass
GTBP0.80-0.03
-3.03%
GT Biopharma
CBUS1.34-0.05
-3.26%
Cibus